Literature DB >> 28306668

A role for intracellular and extracellular DEK in regulating hematopoiesis.

Maegan L Capitano1, Hal E Broxmeyer.   

Abstract

PURPOSE OF REVIEW: Hematopoietic stem/progenitor cell fate decision during hematopoiesis is regulated by intracellular and extracellular signals such as transcription factors, growth factors, and cell-to-cell interactions. In this review, we explore the function of DEK, a nuclear phosphoprotein, on gene regulation. We also examine how DEK is secreted and internalized by cells, and discuss how both endogenous and extracellular DEK regulates hematopoiesis. Finally, we explore what currently is known about the regulation of DEK during inflammation. RECENT
FINDINGS: DEK negatively regulates the proliferation of early myeloid progenitor cells but has a positive effect on the differentiation of mature myeloid cells. Inflammation regulates intracellular DEK concentrations with inflammatory stimuli enhancing DEK expression. Inflammation-induced nuclear factor-kappa B activation is regulated by DEK, resulting in changes in the production of other inflammatory molecules such as IL-8. Inflammatory stimuli in turn regulates DEK secretion by cells of hematopoietic origin. However, how inflammation-induced expression and secretion of DEK regulates hematopoiesis remains unknown.
SUMMARY: Understanding how DEK regulates hematopoiesis under both homeostatic and inflammatory conditions may lead to a better understanding of the biology of HSCs and HPCs. Furthering our knowledge of the regulation of hematopoiesis will ultimately lead to new therapeutics that may increase the efficacy of hematopoietic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28306668      PMCID: PMC5476228          DOI: 10.1097/MOH.0000000000000344

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  65 in total

1.  Structure-specific binding of the proto-oncogene protein DEK to DNA.

Authors:  Tanja Waldmann; Martina Baack; Nicole Richter; Claudia Gruss
Journal:  Nucleic Acids Res       Date:  2003-12-01       Impact factor: 16.971

2.  Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.

Authors:  Luis Miguel Mendes Soares; Katia Zanier; Cameron Mackereth; Michael Sattler; Juan Valcárcel
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

Review 3.  The multifunctional role of EKLF/KLF1 during erythropoiesis.

Authors:  Miroslawa Siatecka; James J Bieker
Journal:  Blood       Date:  2011-05-25       Impact factor: 22.113

4.  Negative regulation of the RelA/p65 transactivation function by the product of the DEK proto-oncogene.

Authors:  Morgan Sammons; Shan Shan Wan; Nancy L Vogel; Edwin J Mientjes; Gerard Grosveld; Brian P Ashburner
Journal:  J Biol Chem       Date:  2006-07-07       Impact factor: 5.157

5.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

6.  Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.

Authors:  Yingfu Ou; Rongjun Xia; Fanyong Kong; Xiaokang Zhang; Shengjin Yu; Lili Jiang; Linlin Zheng; Lijuan Lin
Journal:  Oncol Lett       Date:  2016-01-26       Impact factor: 2.967

Review 7.  Concise review: role of DEK in stem/progenitor cell biology.

Authors:  Hal E Broxmeyer; Nirit Mor-Vaknin; Ferdinand Kappes; Maureen Legendre; Anjan K Saha; Xuan Ou; Heather O'Leary; Maegan Capitano; Scott Cooper; David M Markovitz
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

8.  Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.

Authors:  Xin Liu; Dongdong Qi; Jujie Qi; Zeshu Mao; Xiangdan Li; Jinhui Zhang; Jinzi Li; Wenbin Gao
Journal:  Oncol Rep       Date:  2015-10-30       Impact factor: 3.906

9.  Defining a 0.5-mb region of genomic gain on chromosome 6p22 in bladder cancer by quantitative-multiplex polymerase chain reaction.

Authors:  Andrew J Evans; Brenda L Gallie; Michael A S Jewett; Gregory R Pond; Kirk Vandezande; John Underwood; Yves Fradet; Gloria Lim; Paula Marrano; Maria Zielenska; Jeremy A Squire
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

10.  Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML).

Authors:  Aminetou Mint Mohamed; Marie Balsat; Morgan Thenoz; Catherine Koering; Lea Payen-Gay; Meyling Cheok; Hussein Mortada; Didier Auboeuf; Christiane Pinatel; Mohamed El-Hamri; Charles Dumontet; Emeline Cros; Pascale Flandrin-Gresta; Olivier Nibourel; Claude Preudhomme; Mauricette Michallet; Xavier Thomas; Franck Nicolini; Françoise Solly; Denis Guyotat; Lydia Campos; Eric Wattel; Franck Mortreux
Journal:  Oncotarget       Date:  2016-01-19
View more
  3 in total

1.  Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.

Authors:  Maegan L Capitano; Nirit Mor-Vaknin; Anjan K Saha; Scott Cooper; Maureen Legendre; Haihong Guo; Rafael Contreras-Galindo; Ferdinand Kappes; Maureen A Sartor; Christopher T Lee; Xinxin Huang; David M Markovitz; Hal E Broxmeyer
Journal:  J Clin Invest       Date:  2019-05-20       Impact factor: 14.808

Review 2.  Histone Chaperones as Cardinal Players in Development.

Authors:  Sruthy Manuraj Rajam; Pallavi Chinnu Varghese; Debasree Dutta
Journal:  Front Cell Dev Biol       Date:  2022-04-04

3.  DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling.

Authors:  Maegan L Capitano; Yasser Sammour; James Ropa; Maureen Legendre; Nirit Mor-Vaknin; David M Markovitz
Journal:  J Leukoc Biol       Date:  2022-02-08       Impact factor: 6.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.